MetLife Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
|
|||||
|
2025
Q1 | $1.08M | Sell |
|
|||||
|
2024
Q4 | $1.12M | Buy |
|
|||||
|
2024
Q3 | $995K | Hold |
|
|||||
|
2024
Q2 | $838K | Buy |
|
|||||
|
2024
Q1 | $643K | Hold |
|
|||||
|
2023
Q4 | $628K | Hold |
|
|||||
|
2023
Q3 | $527K | Hold |
|
|||||
|
2023
Q2 | $634K | Buy |
|
|||||
|
2023
Q1 | $596K | Sell |
|
|||||
|
2022
Q4 | $576K | Sell |
|
|||||
|
2022
Q3 | $742K | Hold |
|
|||||
|
2022
Q2 | $769K | Hold |
|
|||||
|
2022
Q1 | $969K | Buy |
|
|||||
|
2021
Q4 | $859K | Hold |
|
|||||
|
2021
Q3 | $775K | Sell |
|
|||||
|
2021
Q2 | $1.82M | Sell |
|
|||||
|
2021
Q1 | $2.16M | Sell |
|
|||||
|
2020
Q4 | $1.52M | Sell |
|
|||||
|
2020
Q3 | $1.49M | Sell |
|
|||||
|
2020
Q2 | $1.79M | Sell |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $1.83M | Sell |
|
|||||
|
2019
Q3 | $1.95M | Sell |
|
|||||
|
2019
Q2 | $2.39M | Sell |
|
|||||
|
2019
Q1 | $2.74M | Sell |
|
|||||
|
2018
Q4 | $3.02M | Buy |
|
|||||
|
2018
Q3 | $2.56M | Hold |
|
|||||
|
2018
Q2 | $1.93M | Hold |
|
|||||
|
2018
Q1 | $1.54M | Hold |
|
|||||
|
2017
Q4 | $1.28M | Buy |
|